149 related articles for article (PubMed ID: 31285853)
1. E1A oncogene induced sensitization to NK cell induced apoptosis requires PIDD and Caspase-2.
Radke JR; Routes JM; Cook JL
Cell Death Discov; 2019; 5():110. PubMed ID: 31285853
[TBL] [Abstract][Full Text] [Related]
2. PIDD-dependent activation of caspase-2-mediated mitochondrial injury in E1A-induced cellular sensitivity to macrophage nitric oxide-induced apoptosis.
Radke JR; Figueroa I; Routes JM; Cook JL
Cell Death Discov; 2018; 4():35. PubMed ID: 30245858
[TBL] [Abstract][Full Text] [Related]
3. E1A enhances cellular sensitivity to DNA-damage-induced apoptosis through PIDD-dependent caspase-2 activation.
Radke JR; Siddiqui ZK; Figueroa I; Cook JL
Cell Death Discov; 2016; 2():16076. PubMed ID: 27833761
[TBL] [Abstract][Full Text] [Related]
4. E1A oncogene enhancement of caspase-2-mediated mitochondrial injury sensitizes cells to macrophage nitric oxide-induced apoptosis.
Radke JR; Siddiqui ZK; Miura TA; Routes JM; Cook JL
J Immunol; 2008 Jun; 180(12):8272-9. PubMed ID: 18523293
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
Routes JM; Ryan S; Morris K; Takaki R; Cerwenka A; Lanier LL
J Exp Med; 2005 Dec; 202(11):1477-82. PubMed ID: 16314433
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D.
Korrer MJ; Routes JM
Results Immunol; 2015; 5():1-5. PubMed ID: 25685658
[TBL] [Abstract][Full Text] [Related]
7. E1A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19 kDa protein.
Cook JL; Routes BA; Leu CY; Walker TA; Colvin KL
Exp Cell Res; 1999 Oct; 252(1):199-210. PubMed ID: 10502412
[TBL] [Abstract][Full Text] [Related]
8. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation.
Shao R; Lee DF; Wen Y; Ding Y; Xia W; Ping B; Yagita H; Spohn B; Hung MC
Mol Cancer Res; 2005 Apr; 3(4):219-26. PubMed ID: 15831675
[TBL] [Abstract][Full Text] [Related]
9. c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors.
Klefstrom J; Kovanen PE; Somersalo K; Hueber AO; Littlewood T; Evan GI; Greenberg AH; Saksela E; Timonen T; Alitalo K
Oncogene; 1999 Apr; 18(13):2181-8. PubMed ID: 10327064
[TBL] [Abstract][Full Text] [Related]
10. MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection.
Routes JM; Ryan JC; Ryan S; Nakamura M
Int Immunol; 2001 Oct; 13(10):1301-7. PubMed ID: 11581175
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL).
Routes JM; Ryan S; Clase A; Miura T; Kuhl A; Potter TA; Cook JL
J Immunol; 2000 Oct; 165(8):4522-7. PubMed ID: 11035092
[TBL] [Abstract][Full Text] [Related]
12. E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S.
Perez D; White E
J Virol; 2003 Feb; 77(4):2651-62. PubMed ID: 12552004
[TBL] [Abstract][Full Text] [Related]
13. E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury.
Cook JL; Routes BA; Walker TA; Colvin KL; Routes JM
Exp Cell Res; 1999 Sep; 251(2):414-23. PubMed ID: 10471326
[TBL] [Abstract][Full Text] [Related]
14. E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes.
Cook JL; Potter TA; Bellgrau D; Routes BA
Oncogene; 1996 Aug; 13(4):833-42. PubMed ID: 8761305
[TBL] [Abstract][Full Text] [Related]
15. Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.
Cook JL; Walker TA; Worthen GS; Radke JR
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9966-71. PubMed ID: 12119420
[TBL] [Abstract][Full Text] [Related]
16. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
Abdool K; Cretney E; Brooks AD; Kelly JM; Swann J; Shanker A; Bere EW; Yokoyama WM; Ortaldo JR; Smyth MJ; Sayers TJ
J Immunol; 2006 Aug; 177(4):2575-83. PubMed ID: 16888019
[TBL] [Abstract][Full Text] [Related]
17. Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells.
Routes JM; Ryan S
J Virol; 1995 Dec; 69(12):7639-47. PubMed ID: 7494272
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Schmelz K; Wieder T; Tamm I; Müller A; Essmann F; Geilen CC; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2004 Sep; 23(40):6743-59. PubMed ID: 15273737
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus E1A, not human papillomavirus E7, sensitizes tumor cells to lysis by macrophages through nitric oxide- and TNF-alpha-dependent mechanisms despite up-regulation of 70-kDa heat shock protein.
Miura TA; Morris K; Ryan S; Cook JL; Routes JM
J Immunol; 2003 Apr; 170(8):4119-26. PubMed ID: 12682242
[TBL] [Abstract][Full Text] [Related]
20. Region E1a of highly oncogenic adenovirus 12 in transformed cells protects against NK but not LAK cytolysis.
Kenyon DJ; Raska K
Virology; 1986 Dec; 155(2):644-54. PubMed ID: 2947382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
